Cargando…
Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy
PURPOSE: To evaluate the effects of intravitreal ranibizumab (IVR) treatment on the blood flow of the optic nerve head (ONH) and of retinal vessels of the peripapillary region of eyes with diabetic macular edema (DME) assessed using laser speckle flowgraphy (LSFG). METHODS: Forty eyes of 30 patients...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035512/ https://www.ncbi.nlm.nih.gov/pubmed/32104710 http://dx.doi.org/10.1155/2020/9496242 |
_version_ | 1783500073347317760 |
---|---|
author | Toto, Lisa Evangelista, Federica Viggiano, Pasquale Erroi, Emanuele D'Onofrio, Giada Libertini, Daniele Porreca, Annamaria D'Aloisio, Rossella Mariacristina, Parravano Di Antonio, Luca Di Nicola, Marta Mastropasqua, Rodolfo |
author_facet | Toto, Lisa Evangelista, Federica Viggiano, Pasquale Erroi, Emanuele D'Onofrio, Giada Libertini, Daniele Porreca, Annamaria D'Aloisio, Rossella Mariacristina, Parravano Di Antonio, Luca Di Nicola, Marta Mastropasqua, Rodolfo |
author_sort | Toto, Lisa |
collection | PubMed |
description | PURPOSE: To evaluate the effects of intravitreal ranibizumab (IVR) treatment on the blood flow of the optic nerve head (ONH) and of retinal vessels of the peripapillary region of eyes with diabetic macular edema (DME) assessed using laser speckle flowgraphy (LSFG). METHODS: Forty eyes of 30 patients treated with IVR for DME were included in this prospective clinical study. Mean blur rate (MBR) and relative flow volume (RFV) of the ONH and of a superior retinal artery and an inferior retinal vein of the peripapillary region were measured using LSFG at baseline, 2 weeks (T1), and 1 month (T2) after IVR injection. In addition, best-corrected visual acuity (BCVA) and central retinal thickness (CRT) were measured in all cases. RESULTS: The BCVA improved and CRT decreased significantly during the follow-up period (p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, CONCLUSION: IVR injection leads to a reduction of ocular blood flow both in the ONH and in the retinal peripapillary vessels associated with peripapillary vessel constriction. The reduction of CRT and related improvement of vision may be related to the changes in ocular blood flow. |
format | Online Article Text |
id | pubmed-7035512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-70355122020-02-26 Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy Toto, Lisa Evangelista, Federica Viggiano, Pasquale Erroi, Emanuele D'Onofrio, Giada Libertini, Daniele Porreca, Annamaria D'Aloisio, Rossella Mariacristina, Parravano Di Antonio, Luca Di Nicola, Marta Mastropasqua, Rodolfo Biomed Res Int Research Article PURPOSE: To evaluate the effects of intravitreal ranibizumab (IVR) treatment on the blood flow of the optic nerve head (ONH) and of retinal vessels of the peripapillary region of eyes with diabetic macular edema (DME) assessed using laser speckle flowgraphy (LSFG). METHODS: Forty eyes of 30 patients treated with IVR for DME were included in this prospective clinical study. Mean blur rate (MBR) and relative flow volume (RFV) of the ONH and of a superior retinal artery and an inferior retinal vein of the peripapillary region were measured using LSFG at baseline, 2 weeks (T1), and 1 month (T2) after IVR injection. In addition, best-corrected visual acuity (BCVA) and central retinal thickness (CRT) were measured in all cases. RESULTS: The BCVA improved and CRT decreased significantly during the follow-up period (p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, p < 0.010). MBR-related parameters of the ONH such as MBR of all area (MA), MBR of vascular area (MV), and MBR of tissue area (MT) decreased significantly at 2 weeks after IVR compared to baseline values (MA, CONCLUSION: IVR injection leads to a reduction of ocular blood flow both in the ONH and in the retinal peripapillary vessels associated with peripapillary vessel constriction. The reduction of CRT and related improvement of vision may be related to the changes in ocular blood flow. Hindawi 2020-02-10 /pmc/articles/PMC7035512/ /pubmed/32104710 http://dx.doi.org/10.1155/2020/9496242 Text en Copyright © 2020 Lisa Toto et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Toto, Lisa Evangelista, Federica Viggiano, Pasquale Erroi, Emanuele D'Onofrio, Giada Libertini, Daniele Porreca, Annamaria D'Aloisio, Rossella Mariacristina, Parravano Di Antonio, Luca Di Nicola, Marta Mastropasqua, Rodolfo Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy |
title | Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy |
title_full | Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy |
title_fullStr | Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy |
title_full_unstemmed | Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy |
title_short | Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy |
title_sort | changes in ocular blood flow after ranibizumab intravitreal injection for diabetic macular edema measured using laser speckle flowgraphy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035512/ https://www.ncbi.nlm.nih.gov/pubmed/32104710 http://dx.doi.org/10.1155/2020/9496242 |
work_keys_str_mv | AT totolisa changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT evangelistafederica changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT viggianopasquale changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT erroiemanuele changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT donofriogiada changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT libertinidaniele changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT porrecaannamaria changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT daloisiorossella changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT mariacristinaparravano changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT diantonioluca changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT dinicolamarta changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy AT mastropasquarodolfo changesinocularbloodflowafterranibizumabintravitrealinjectionfordiabeticmacularedemameasuredusinglaserspeckleflowgraphy |